53 results on '"Joffe, Hadine"'
Search Results
2. NAMS 2021 Utian Translational Science SymposiumSeptember 2021, Washington, DCCharting the path to health in midlife and beyond: the biology and practice of wellness
3. COVID-19 Threatens Progress Toward Gender Equity Within Academic Medicine
4. Lights on MsFLASH: a review of contributions
5. Identifying women who share patterns of reproductive hormones, vasomotor symptoms, and sleep maintenance problems across the menopause transition: group-based multi-trajectory modeling in the Study of Womenʼs Health Across the Nation
6. To the Editor
7. Antimullerian Hormone and Impending Menopause in Late Reproductive Age: The Study of Womenʼs Health Across the Nation
8. NAMS 2019 Pre-Meeting Symposium, September 2019, Chicago Illinois: The Perimenopause
9. Workshop on normal reference ranges for estradiol in postmenopausal women: commentary from The North American Menopause Society on low-dose vaginal estrogen therapy labeling
10. Effects of NT-814, a dual neurokinin 1 and 3 receptor antagonist, on vasomotor symptoms in postmenopausal women: a placebo-controlled, randomized trial
11. Trajectory analysis of sleep maintenance problems in midlife women before and after surgical menopause: the Study of Womenʼs Health Across the Nation (SWAN)
12. Trajectory analysis of sleep maintenance problems in midlife women before and after surgical menopause: the Study of Womenʼs Health Across the Nation (SWAN)
13. Cardiovascular reactivity and psychological hyperarousal in hot flash-associated insomnia disorder
14. Menopausal hormone therapy trends before versus after 2002: impact of the Womenʼs Health Initiative Study Results
15. Effects of Pharmacologic and Nonpharmacologic Interventions on Insomnia Symptoms and Self-reported Sleep Quality in Women With Hot Flashes: A Pooled Analysis of Individual Participant Data From Four MsFLASH Trials
16. Confirmatory factor analysis of the Insomnia Severity Index (ISI) and invariance across race: a pooled analysis of MsFLASH data
17. Menopausal hormone therapy trends before versus after 2002: impact of the Womenʼs Health Initiative Study Results
18. Association between HIV status and psychological symptoms in perimenopausal women
19. Should Hormone Therapy Be Used to Prevent Depressive Symptoms During the Menopause Transition?
20. Lifelong estradiol exposure and risk of depressive symptoms during the transition to menopause and postmenopause
21. Treatment of Premenstrual Breakthrough of Depression With Adjunctive Oral Contraceptive Pills Compared With Placebo
22. Vaginal microbiota and genitourinary menopausal symptoms: a cross-sectional analysis
23. Association of estradiol with sleep apnea in depressed perimenopausal and postmenopausal women: a preliminary study
24. Shifting Paradigms About Hormonal Risk Factors for Postmenopausal Depression: Age at Menopause as an Indicator of Cumulative Lifetime Exposure to Female Reproductive Hormones
25. Trajectories of Vasomotor Symptoms and Carotid Intima Media Thickness in the Study of Women’s Health Across the Nation
26. Menopausal quality of life: RCT of yoga, exercise, and omega-3 supplements
27. Concern About the Use of Venlafaxine to Treat Vasomotor Symptoms—Reply
28. Duration of Menopausal Vasomotor Symptoms Over the Menopause Transition
29. Effects of Escitalopram on Markers of Bone Turnover: A Randomized Clinical Trial
30. Sexual Function in Women on Estradiol or Venlafaxine for Hot Flushes: A Randomized Controlled Trial
31. Low-Dose Estradiol and the Serotonin-Norepinephrine Reuptake Inhibitor Venlafaxine for Vasomotor Symptoms: A Randomized Clinical Trial
32. Eszopiclone improves insomnia and depressive and anxious symptoms in perimenopausal and postmenopausal women with hot flashes: a randomized, double-blinded, placebo-controlled crossover trial
33. The Impact of Depot GnRH Agonist on AMH Levels in Healthy Reproductive-Aged Women
34. Disparate Rates of New-Onset Depression During the Menopausal Transition in 2 Community-based Populations: Real, or Really Wrong?
35. PSYCHOSOCIAL FEATURES ASSOCIATED WITH LIFETIME COMORBIDITY OF MAJOR DEPRESSION AND ANXIETY DISORDERS AMONG A COMMUNITY SAMPLE OF MID-LIFE WOMEN: THE SWAN MENTAL HEALTH STUDY
36. Vasomotor Symptoms and Insulin Resistance in the Study of Womenʼs Health Across the Nation
37. Metabolic Activity in the Insular Cortex and Hypothalamus Predicts Hot Flashes: An FDG-PET Study
38. Trajectory Clustering of Estradiol and Follicle-Stimulating Hormone during the Menopausal Transition among Women in the Study of Womenʼs Health across the Nation (SWAN)
39. Lifetime History of Depression and Anxiety Disorders as a Predictor of Quality of Life in Midlife Women in the Absence of Current Illness Episodes
40. Increased Estradiol and Improved Sleep, But Not Hot Flashes, Predict Enhanced Mood during the Menopausal Transition
41. Efficacy of Escitalopram for Hot Flashes in Healthy Menopausal Women: A Randomized Controlled Trial
42. Evaluation and Management of Sleep Disturbance during the Menopause Transition
43. Menopause-associated Symptoms and Cognitive Performance: Results From the Study of Womenʼs Health Across the Nation
44. Gains in Body Fat and Vasomotor Symptom Reporting Over the Menopausal Transition: The Study of Womenʼs Health Across the Nation
45. Interpreting Incidence of Hospitalization for Postpartum Psychotic and Bipolar Episodes Study
46. Menstrual Cycle Dysfunction Associated with Neurologic and Psychiatric Disorders
47. Incidence of Hospitalization for Postpartum Psychotic and Bipolar Episodes in Women With and Without Prior Prepregnancy or Prenatal Psychiatric Hospitalizations
48. Use of antidepressants during perimenopause
49. Sociodemographic predictors of antenatal and postpartum depressive symptoms among women in a medical group practice
50. Gender differences in bipolar disorder: retrospective data from the first 500 STEP-BD participants
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.